著者
Nicolas Girerd Matthieu Aubry Pierre Lantelme Olivier Huttin Patrick Rossignol
出版者
International Heart Journal Association
雑誌
International Heart Journal (ISSN:13492365)
巻号頁・発行日
vol.62, no.1, pp.193-196, 2021-01-30 (Released:2021-01-30)
参考文献数
9
被引用文献数
3 3

Intravenous mineralocorticoid receptor antagonists (MRAs) have been used in some centers for decades to reduce the risk of hypokalemia and boost diuresis in acutely decompensated heart failure (ADHF). We report the well-tolerated use of intravenous MRAs as a rescue procedure in 3 patients admitted for ADHF with important diuretic resistance. Undertaking trials evaluating the effect of this therapeutic strategy in ADHF could represent a promising avenue.

言及状況

外部データベース (DOI)

Twitter (1 users, 1 posts, 1 favorites)

And let's not forgot the Canrenoate option. We published some rescue cases https://t.co/SVejeVvYNG Actually I learn cardiology like that in Lyon, IV furosemide and 200 mg of IV canrenoate 2 to 3 times a day. Published only recently here https://t.co/zoU8zjPZYT https://t.co/40dCFXWXh7

収集済み URL リスト